Table 4 Adverse cardiac events at 6 and 12 months
Event | Total events at 6 months | Total events at 12 months | Diabetes | Small vessel | CTO | AMI |
|---|---|---|---|---|---|---|
n = 150 | n = 150 | N = 48 | N = 75 | N = 17 | N = 80 | |
Target lesion failure | 5(3.3) | 8(5.3) | 3(6.4) | 3(4.1) | 1(5.9) | 4(5.0) |
Cardiac death | 5(3.3) | 8(5.3) | 3(6.4) | 3(4.1) | 1(5.9) | 4(5.0) |
Target vessel myocardial infarction | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) |
Emergent CABG surgery | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) |
Clinically driven target lesion revascularization | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) |
All-cause death | 7(4.7) | 11(7.3) | 1(2.1) | 6(8.1) | 2(11.8) | 5(6.3) |
All myocardial infarction | 1(0.7) | 2(1.3) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) |
Non-target vessel myocardial infarction | 0(0.0) | 1(0.7) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) |
Target vessel revascularization | 0(0.0) | 1(0.7) | 0(0.0) | 0(0.0) | 0(0.0) | 1(1.3) |
Non-target vessel revascularization | 0(0.0) | 2(1.3) | 1(2.1) | 0(0.0) | 0(0.0) | 1(1.3) |
Definite or probable stent thrombosis | 1(0.7) | 2(1.3) | 1(2.1) | 0(0.0) | 0(0.0) | 1(1.3) |
Definite | 0(0.0) | 1(0.7) | 1(2.1) | 0(0.0) | 0(0.0) | 0(0.0) |
Probable | 1(0.7) | 1(0.7) | 0(0.0) | 0(0.0) | 0(0.0) | 1(1.3) |